Please login to the form below

Not currently logged in
Email:
Password:

business strategy

This page shows the latest business strategy news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA and Aqilion AB partner in potential €960m deal

Merck KGaA and Aqilion AB partner in potential €960m deal

Commenting on the recent partnership, Aqilion’s chief executive officer, Sarah Fredriksson, said: “We are delighted and proud to announce this collaboration with Merck as it validates our business strategy of ... generating highly innovative

Latest news

More from news
Approximately 12 fully matching, plus 146 partially matching documents found.

Latest Intelligence

  • Reimagining strategy development for a hybrid workforce Reimagining strategy development for a hybrid workforce

    If your competitor makes a big strategic move the day after you’ve put the finishing touches to this year’s business strategy, it may be out of date before ... folders. Digitalisation of your approach to strategy is not, of course, the whole solution.

  • The pursuit of patient diversity in clinical trials The pursuit of patient diversity in clinical trials

    Patient-centricity was a conversation about good intentions rather than business critical,” said Mark Evans. ... That’s a business strategy challenge and it needs to be considered from the get-go – when companies are deciding where they want to play

  • Strategy experts: the real thing Strategy experts: the real thing

    What defines genuine strategy experts in the biomedical industry? The biomedical business applies massive means to meet essential ends. ... In the biomedical business, ‘publication strategy’ and ‘meetings strategy’, for example, fail to meet

  • Integrating competitive intelligence into business development, licensing and M&A strategy Integrating competitive intelligence into business development, licensing and M&A strategy

    One of the most profitable areas for biopharma companies to see the greatest return on their competitive intelligence (CI) investment is through its application to business development and licensing (BD&L) ... Alfred Reszka is Chief Business Officer of

  • Is creativity in quarantine? Is creativity in quarantine?

    However, in recent years, models to help quantify the links between creativity and business performance have advanced. ... This never goes away. However, we are seeing more and more functions across client organisations, access, medical, business strategy

More from intelligence
Approximately 3 fully matching, plus 37 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 74 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 7 fully matching, plus 46 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
fox&cat

Fox&cat is a new kind of fully-integrated communications agency – one that delivers genuinely inspirational campaigns and programmes with equal...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...